Richard Rustandi

Dr. Richard R. Rustandi is a Senior Principle Scientist in Vaccine Analytical Research Development at Merck Co. He obtained his BS in Chemistry from University of Hawaii and his MS and PhD in Chemistry from University of Chicago. He did his postdoctoral work in Institute of Physical Chemistry at University of Zurich, Switzerland and continued at Harvard Medical School and finally at University of Maryland studying protein structure using multi-dimensional NMR spectroscopy. His current research focus is the development and application of various capillary electrophoresis and other separation techniques in vaccines and therapeutic proteins. The main emphasis is on capillary western advancement towards streamlining the analytical development of vaccine products from end to end including host cell proteins. In addition, CZE development on many different types of virus such as live-attenuated, VLP, oncolytic, gene-therapy as well LNP is also main focus. Another area of interest is receptor-antigen binding using various methods such as ACE, SPR, automated ELISA, ITC, size-based separation, Fluidity-diffusion, as well as NMR and EPR spectroscopies. He is currently an Associate Director at CASSS, Distinguish Member of Advisory Board at Ewha Woman University (S. Korea), Member of Editorial Board of Electrophoresis Journal, Merck Scientific Excellence Core Team member, and CE Pharm committee 2012-2020.